I didn't think I would have any future - but olaparib gave me hope

Fiona and her husband looked forward to retiring together and often talked about their plans. But out of nowhere Fiona was diagnosed with advanced ovarian cancer, and their lives were turned completely upside down. Thankfully, a drug called olaparib gave them hope for the future. 

So many people were involved in the development of olaparib, from Professor Steve Jackson and all the scientists carrying out the research, to the Curestarters like you who helped fund it. To every single person, I would like to say thank you from the bottom of my heart. You have given me more time to live my life, with the people I love – and given me hope for the future.  

Curestarter Fiona

I live with my husband in a lovely village in south Perthshire. We love to go walking together, visit family and friends across the country and, when we can, travel further afield. 

I worked in the NHS for 40 very rewarding years in a variety of different roles – as a nurse, a midwife, a health visitor, an occupational health nurse, a researcher, and finally a further education lecturer.

I didn’t intend on retiring for at least another four or five years, but sadly I had to take ill-health early retirement when I became unwell. It was a very strange way to finish my career.

I was on annual leave when I had the appointment that changed everything. 

I had been experiencing some nagging symptoms, but I was convinced that it would all be down to something very minor that could be easily dealt with – so convinced that I had postponed my appointment for a week, because of our holiday plans.

But as soon as I saw the gynaecologist, I knew she suspected something much more serious. A whirlwind of tests followed – an internal ultrasound, blood tests and then a CT scan.

My husband and I tried to fill the time waiting for the results by visiting local areas and going for long walks, but my overwhelming memory is of being full of anxiety.

Soon it was confirmed – I had ovarian cancer. Then, not long after, a biopsy revealed the cancer was advanced. It was devastating to get that news and we were both so scared.

All I could think about was of my experience working in gynaecology and of the people I had met on the ward. I knew all too well how few treatments had been available for ovarian cancer for such a long time, and I had seen far too many patients sent home with the unthinkable knowledge that there were no options left.

It was always absolutely devastating to see them leave, knowing that there was nothing more that could be done for them. And now I was facing that same dread and uncertainty. It felt impossible to make any plans for the future because I was convinced that it was a future I wouldn’t be here for.

I was booked in for surgery just two weeks after the biopsy results, a scary prospect as the operation was a major one. 

After I recovered I started six months of chemotherapy - I coped quite well and remained as positive as I could, but I found it quite traumatic to lose my hair. I’m a redhead, so it was a big part of my identity. Still, I smiled as I entered the chemotherapy unit, glad to start treatment that would hopefully knock out the cancer cells.

Seven weeks after I completed my chemotherapy, I began taking olaparib. I was considered a good fit as I had the BRCA2 mutation – something that surprised me at the time, as I had no history of breast or ovarian cancer in my family. 

My oncologist explained a clinical trial had recently shown significant benefits of treatment with olaparib in patients with advanced ovarian cancer.

It does make me feel very lucky in a way, that my diagnosis happened when it did – after this clinical trial had taken place and olaparib had been approved for use by the NHS.

Sadly, I know that for many people, this wasn’t the case.

Prior to the development of olaparib and other drugs like it, there had been no real change in the treatment of advanced ovarian cancer for decades, and the outlook was grim for most patients. But olaparib was a complete game-changer. It’s been revolutionary for the treatment of ovarian cancer.

I have done well on olaparib and incredibly I have now reached a stage where most of the time I can put cancer to the back of my mind.

I turned 60 recently and my husband and I celebrated our 30th wedding anniversary. It’s difficult to put into words how extremely grateful I am that I now feel like I have a future.

By becoming a Curestarter, you can help us fund more lifesaving research around the world that will give hope to people like Fiona. Join our united effort to reach a day when no life is cut short by cancer. 

Donate now & become a Curestarter

Be part of a united effort to stop lives being cut short by cancer.

Curestarter Alice and Dr Jamie team smile for a photo with the rest of the University College London lab team after a tour of the Worldwide Cancer Research project
Real life impact
Finding cures for cancer is my dream
Finding cures for cancer is my dream
Real life impact
Helping to diagnose rare genetic diseases
Helping to diagnose rare genetic diseases
Dario Alessi in the lab
Real life impact
Repurposing a diabetes drug for cancer treatment
Repurposing a diabetes drug for cancer treatment
Share this page